A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour Deficiencies

20217 citationsJournal Articlebronze Open Access

Authors

Derek Jones · Skin Care and Laser Physicians of Beverly Hills

Leslie Baumann · Baumann Cosmetic Dermatology

Amir Moradi · Baumann Cosmetic Dermatology

Sachin M. Shridharani

Melanie D. Palm · Skin Cancer Foundation

Craig Teller

Mark Taylor · Gateway Aesthetic Institute and Laser Center

Theda C. Kontis

Abstract

 HARC was well tolerated and non-inferior to Control for correction of midface fullness at 12 weeks after last injection. Aesthetic improvement and subject satisfaction were high and lasted through week 48.  J Drugs Dermatol. 2021;20(9):949-956. doi:10.36849/JDD.6191.

Topics & Keywords

Facial Rejuvenation and Surgery Techniques Orthodontics and Dentofacial Orthopedics Dermatologic Treatments and Research

Publication Details

Published in: Journal of Drugs in Dermatology

Volume 20, Issue 9, pp. 949-956

DOI: 10.36849/jdd.6191

Field-Weighted Citation Impact: 0.80

Command Palette

A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour Deficiencies

Authors

Abstract

Topics & Keywords

Publication Details